======= PPIE ======= == Gene Information == * **Official Symbol**: PPIE * **Official Name**: peptidylprolyl isomerase E * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10450|10450]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UNP9|Q9UNP9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PPIE&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PPIE|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602435|Open OMIM]] == Function Summary == * **Entrez Summary**: The protein encoded by this gene is a member of the peptidyl-prolyl cis-trans isomerase (PPIase) family. PPIases catalyze the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and accelerate the folding of proteins. This protein contains a highly conserved cyclophilin (CYP) domain as well as an RNA-binding domain. It was shown to possess PPIase and protein folding activities, and it also exhibits RNA-binding activity. Alternative splicing results in multiple transcript variants. A related pseudogene, which is also located on chromosome 1, has been identified. [provided by RefSeq, Aug 2010]. * **UniProt Summary**: N/A |Pro isomerase| |RRM 1| |poly(A) binding| |cyclosporin A binding| |U2-type catalytic step 2 spliceosome| |positive regulation of viral genome replication| |protein refolding| |peptidyl-prolyl cis-trans isomerase activity| |protein peptidyl-prolyl isomerization| |peptidyl-proline modification| |positive regulation of viral life cycle| |transcription-coupled nucleotide-excision repair| |catalytic step 2 spliceosome| |regulation of viral genome replication| |positive regulation of viral process| |nucleotide-excision repair| |secretory granule lumen| |ficolin-1-rich granule lumen| |unfolded protein binding| |regulation of viral life cycle| |mRNA binding| |regulation of viral process| |regulation of symbiosis, encompassing mutualism through parasitism| |protein folding| |RNA splicing, via transesterification reactions with bulged adenosine as nucleophile| |mRNA splicing, via spliceosome| |RNA splicing, via transesterification reactions| |RNA splicing| |nuclear speck| |mRNA processing| |neutrophil degranulation| |neutrophil activation involved in immune response| |neutrophil mediated immunity| |neutrophil activation| |granulocyte activation| |DNA repair| |positive regulation of multi-organism process| |leukocyte degranulation| |myeloid leukocyte mediated immunity| |myeloid cell activation involved in immune response| |myeloid leukocyte activation| |leukocyte activation involved in immune response| |cell activation involved in immune response| |mRNA metabolic process| |regulated exocytosis| |DNA metabolic process| |leukocyte mediated immunity| |cellular response to DNA damage stimulus| |regulation of multi-organism process| |exocytosis| |RNA processing| |peptidyl-amino acid modification| |leukocyte activation| |secretion by cell| |export from cell| |cell activation| |immune effector process| |secretion| |RNA binding| |RNA metabolic process| |cellular response to stress| |immune response| |extracellular region| |vesicle-mediated transport| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|1.75| |[[:results:exp260|ABT-702 0.1μM R06 exp260]]|1.76| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|1.8| ^Gene^Correlation^ |[[:human genes:c:cactin|CACTIN]]|0.469| |[[:human genes:r:rpl38|RPL38]]|0.444| |[[:human genes:p:psmd3|PSMD3]]|0.44| |[[:human genes:c:cbwd3|CBWD3]]|0.431| |[[:human genes:c:cdca3|CDCA3]]|0.43| |[[:human genes:c:ckap5|CKAP5]]|0.426| |[[:human genes:t:tfip11|TFIP11]]|0.425| |[[:human genes:s:supt5h|SUPT5H]]|0.424| |[[:human genes:s:srsf1|SRSF1]]|0.422| |[[:human genes:c:cdk8|CDK8]]|0.421| |[[:human genes:t:ticrr|TICRR]]|0.419| |[[:human genes:p:psmc5|PSMC5]]|0.419| |[[:human genes:a:atp6v1c1|ATP6V1C1]]|0.419| |[[:human genes:r:rpl35|RPL35]]|0.418| |[[:human genes:i:ik|IK]]|0.417| |[[:human genes:n:narfl|NARFL]]|0.417| |[[:human genes:r:rbm39|RBM39]]|0.417| |[[:human genes:n:nip7|NIP7]]|0.415| |[[:human genes:s:setd1a|SETD1A]]|0.413| |[[:human genes:p:psmb2|PSMB2]]|0.411| |[[:human genes:t:tbc1d3h|TBC1D3H]]|0.41| |[[:human genes:p:pola2|POLA2]]|0.409| |[[:human genes:c:cwc22|CWC22]]|0.408| |[[:human genes:p:psmb4|PSMB4]]|0.406| |[[:human genes:c:cdc6|CDC6]]|0.406| |[[:human genes:r:rpl34|RPL34]]|0.403| Global Fraction of Cell Lines Where Essential: 111/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|6/28| |blood|2/28| |bone|1/26| |breast|5/33| |central nervous system|7/56| |cervix|0/4| |colorectal|3/17| |esophagus|4/13| |fibroblast|0/1| |gastric|5/16| |kidney|4/21| |liver|2/20| |lung|13/75| |lymphocyte|2/16| |ovary|2/26| |pancreas|2/24| |peripheral nervous system|5/16| |plasma cell|0/15| |prostate|1/1| |skin|1/24| |soft tissue|3/9| |thyroid|1/2| |upper aerodigestive|3/22| |urinary tract|5/29| |uterus|1/5| == Essentiality in NALM6 == * **Essentiality Rank**: 438 * **Expression level (log2 read counts)**: 5.06 {{:chemogenomics:nalm6 dist.png?nolink |}}